Emerging Market Target the mid-size aesthetics device segment with growth potential, leveraging ABM's $1M-$10M revenue range and recent FDA-cleared Vivace Ultra device to position as a scalable partner for clinics expanding non-surgical aesthetic offerings.

Strategic Partnerships Capitalize on ABM's existing partnerships such as U Dermatology Partners and Dermatology Center Plano to pursue co-marketing and exclusive distribution arrangements for Vivace Ultra, driving network effects and faster adoption.

Clinical Validation Highlight FDA clearance and published clinical findings for the Vivace Ultra to support training, onboarding, and risk-adjusted procurement discussions, appealing to clinics prioritizing evidence-based devices.

Expansion Readiness Position ABM for growth with a ready-to-scale sales engine, leveraging recent leadership additions in sales and regulatory teams and a growing physician network to accelerate territory coverage and service delivery.

Tech & Marketing Aero Leverage ABM's tech stack and digital channels (Salesforce, Shopify, Klaviyo, Google Cloud) to enable targeted campaigns, automated lead nurturing, and streamlined dealer/distributor onboarding to shorten sales cycles.